🧬Immunotherapy / Immuno-Oncology
Market Cap$86.1B
1D+1.46%
Companies455
Public Cos79
SECTOR MARKET CAP
$86.1B-72.9%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | Germany | $23.0B | BNTX |
| 2 |  | China | $9.7B | 9926.HK |
| 3 |  | Denmark | $8.6B | ALK-B.CO |
| 4 |  | United States | $7.6B | IBRX |
| 5 |  | Japan | $6.8B | 4528.T |
| 6 |  | United States | $5.7B | CGON |
| 7 |  | United States | $1.9B | IOVA |
| 8 |  | United States | $1.8B | PGEN |
| 9 |  | United States | $1.7B | SLS |
| 10 |  | Switzerland | $1.6B | MLTX |
| 11 |  | United States | $1.6B | VIR |
| 12 |  | United States | $1.6B | BCAX |
| 13 |  | United Kingdom | $1.5B | IMCR |
| 14 |  | Germany | $1.4B | IMTX |
| 15 |  | United States | $1.3B | ZBIO |
| 16 |  | France | $939.3M | DBVT |
| 17 |  | United States | $894.6M | JANX |
| 18 |  | United States | $887.2M | REPL |
| 19 |  | United States | $813.1M | VOR |
| 20 |  | United Kingdom | $602.8M | AGY.L |